Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2016

Mar 14, 2016

30198_dirs_2016-03-14_151f2240-7585-47b7-baed-1d6251e6facd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2016-03-10

Reporting Person: MOY JEFFREY (SVP, Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-03-11 Common Stock J 8334.0 $65.15 Disposed 76333 Direct
2016-03-10 Common Stock D 3321.0 $63.18 Disposed 78612 Indirect
2016-03-10 Common Stock D 6532.0 $63.18 Disposed 72080 Indirect
2016-03-11 Common Stock J 8334.0 $65.15 Acquired 80414 Indirect

Footnotes

F1: Shares were transferred from direct ownership to ownership under the Moy Family Trust upon vesting of previously awarded restricted stock units.

F2: Included in this number are 76,333 unvested restricted stock units, 33,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 26,666 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 16,667 of which were granted on March 8, 2014 and shall vest through March 08, 2017.

F3: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.

F4: Shares are held by the Moy Family Trust U/A/D 12/09/2013, with respect to which the reporting person is a trustee.